Immupharma Share Discussion Threads

[criticalthinker1] 04/1/2023 15:11

Going to say it again....this rise is overdue!

[truthcaller] 04/1/2023 15:03

Chasers are out in full force chasing anything then selling at losses

[tomboyb] 04/1/2023 14:51

This will break 2.5p -

[lord loads of lolly] 28/12/2022 08:59

colsmith - I think we all agree by now that anything Tim says can safely be ignored. Facts speak louder than words - and the facts have pretty much always contradicted Tim’s ill-placed optimism.

[colsmith] 23/12/2022 11:33

Just read Tim's message - this is a difficult one to call as Tim shall we say has been a tad optimistic, however maybe one can say:

- optimistic view that thing's are on track and unless any thing comes out of the woodwork the FDA will support the to be proposed trial, and if so there's a good chance of success as the FDA have had a major impact on the trial structure..

- pessimistic view is that Tim and board are being too optimistic and FDA are playing ducks and drakes.

Have a pleasant Christmas and too all at Immupharma

[chesty1] 23/12/2022 08:59

tomboyb22 Dec '22 - 08:58 - 38424 of 38425
0 0 0
Quick trade to above 2p -

NOT A CHANCE!

[eva1989] 22/12/2022 21:15

Hi halfbutt - That flat is for life! Should have put more into real estate than IMM post SNG success.

I've now decent into Destiny Pharma... worth a risk. They have 2 P3 ready to go. Todays trading update RSN should help to summaries.

And this is my last message here in this board...

Good luck..

[tomboyb] 22/12/2022 08:58

Quick trade to above 2p -

[lord loads of lolly] 19/12/2022 19:21

Eva Perone - I fear your destiny is less pharma. More the cappuccino maker.

[halfbutt] 19/12/2022 19:19

Me too eva... hope you still have hammersmith xxx

[eva1989] 19/12/2022 10:14

Booked decent loss

Heartbreaking but I'm now done with IMM.

Onto Destiny Pharma now

[arlington chetwynd talbott] 17/12/2022 13:05

You are maybe confusing me with Arlington Chetwynd Talbot - we are different people.

[andymunchkin] 17/12/2022 12:39

ACT ru the reAlOne orA clone??

[arlington chetwynd talbott] 17/12/2022 12:34

You may be right, but you seem to say that about every share.

[neo26] 16/12/2022 22:42

Well another placing coming?

[ken chung] 16/12/2022 16:15

Timberrrrrrrrr!Lemmings and mushrooms only!

[neo26] 16/12/2022 11:12

What is imm actually doing now?

[supernumerary] 24/11/2022 16:36

Interesting development in lupus treatment:



CAR T cell therapy could reach beyond cancer
by Perelman School of Medicine at the University of Pennsylvania

Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small set of patients with the autoimmune disease lupus. Penn Medicine CAR T pioneer Carl June, MD, and Daniel Baker, a doctoral student in Cell and Molecular Biology in the Perelman School of Medicine at the University of Pennsylvania, discuss this development in a commentary published today in Cell.

[ ... ]

The commentary from June and Baker comes in response to the first significant clinical report of success from these efforts: a paper in Nature Medicine from German researchers on the use of CAR T therapy against the autoimmune disease lupus (systemic lupus erythematosus).

Researchers say lupus is an obvious choice for CAR T therapy because it too is driven by B cells, and thus experimental CAR T therapies against it can employ existing anti-B-cell designs. B cells are the immune system's antibody-producing cells, and, in lupus, B cells arise that attack the patient's own organs and tissues.

In the German study, the patients—five young adults—did not benefit from standard lupus treatments. Yet, all went into remission, and were able to stop taking their lupus drugs within three months of a single, relatively small dose of CAR T therapy, which essentially removed their existing B cells. (Cancer patients subsequently require infusions of purified human antibodies from healthy volunteers, to maintain some antibody immunity.)

Even more remarkably, all the patients remained in remission during the follow-up period of up to a year, and unlike cancer patients, the lupus patients experienced the return of their B cells, which are naturally replenished from blood stem cells in bone marrow.

[ ... ]

[victor2] 24/11/2022 11:06

Just spotted that stanford have issued an updated research
note this morning can be seen on their website,also on research tree
if you use that.

[neo26] 14/11/2022 18:32

Its true he did say that in interview. Now we know why all those warrants price reduced to 5p, they expected this but mislead investors.